Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
6.98
+0.49 (7.55%)
At close: Apr 24, 2026, 4:00 PM EDT
6.74
-0.24 (-3.44%)
After-hours: Apr 24, 2026, 7:26 PM EDT
Verrica Pharmaceuticals Market Cap
Verrica Pharmaceuticals has a market cap or net worth of $119.91 million as of April 24, 2026. Its market cap has increased by 182.24% in one year.
Market Cap
119.91M
Enterprise Value
91.39M
1-Year Change
182.24%
Ranking
Category
Stock Price
$6.98
Market Cap Chart
Since June 15, 2018, Verrica Pharmaceuticals's market cap has decreased from $436.56M to $119.91M, a decrease of -72.53%. That is a compound annual growth rate of -15.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 119.91M | -9.76% |
| Dec 31, 2025 | 132.88M | 109.60% |
| Dec 31, 2024 | 63.40M | -79.41% |
| Dec 29, 2023 | 307.91M | 172.47% |
| Dec 30, 2022 | 113.01M | -55.17% |
| Dec 31, 2021 | 252.07M | -15.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| KALA BIO | 126.50M |
| Innate Pharma | 123.03M |
| Oncolytics Biotech | 119.61M |
| Pyxis Oncology | 119.38M |
| NeOnc Technologies Holdings | 119.08M |
| Aardvark Therapeutics | 117.59M |
| Cardiff Oncology | 117.59M |
| Immunic | 114.82M |